NOX4 and neoplasm: Furthermore, we show that NOX4 inhibition in CAFs can abrogate the tumor-promoting function of these cells in vitro and in vivo and that this effect can be achieved pharmacologically (using GKT137831), identifying this enzyme as a druggable therapeutic target.